Objective: To describe the pro file of surgeons who treat patients with inflammatory bowel disease as well as the characteristics of inflammatory bowel disease care, unmet demands, and difficulties. Methods: The research participants answered a Google Forms questionnaire. Results: Of the 99 surgeons who...
Purpose: To investigate the impact of the Chinese medicine compound Ento-PB on oxazolone (OXZ)-induced ulcerative colitis (UC) in rats. Methods: UC rats induced by OXZ were treated with Ento-PB. The damage to the colon was assessed using several measures, including the disease activity index (DAI), colon...
Objective: To evaluate the application of proactive pro-drug therapy (TDM) at week six in users of infliximab therapy in ulcerative colitis patients and to analyze the need for further disease optimization. Method: This is a retrospective analysis that will be carried out simultaneously at the Hospital d...
Garnevi Fávero, Aline;
Nascimento da Silva, Karina;
Rodrigues Ribeiro, Willian;
Marcantonio Ferreira, Caroline;
Sartorelli, Patrícia;
Cardili, Leonardo;
De Cássia Sinigaglia, Rita;
Bertaglia Pereira, Joice Naiara;
Aparecido da Silva, Marcelo;
Vilegas, Wagner;
Dias Silva, Marcelo José;
Ribeiro Paiotti, Ana Paula.
Introduction. Anti-inflammatories, immunosuppressants, and immunobiological are commonly used in the treatment of inflammatory bowel disease. However, some patients do not present an adequate response or lose effective response during the treatment. A recent study found a potential anti-inflammatory effe...
Besser, Nicolás;
Chacón, Erika;
Iglesias, Andrés;
Álvarez-Lobos, Manuel;
Pavez, Carolina;
Villalón, Constanza;
Urrejola, Gonzalo;
Zúñiga, Álvaro;
Molina, María Elena;
Miguieles, Rodrigo;
Bellolio, Felipe.
BACKGROUND: Treatment for moderate-severe active ulcerative colitis (UC) includes steroids, biologic therapy and total colectomy. Aim: To describe the features of patients with moderate to severe active UC, their hospital evolution and need for colectomy. MATERIAL AND METHODS: Non-concurrent cohort study...
Silent or subclinical inflammatory bowel diseases (IBD) is a relatively new term that has been used to describe individuals with asymptomatic active mucosal bowel inflammation, often unaware of their disease due to either the lack of or mild inflammatory symptoms. These patients are at risk for gastroint...
Ulcerative colitis (UC) affects the mucosa and submucosa of the large intestine. One of the mechanisms involved in its etiology is oxidative stress (OS), directly involved in the inflammatory process characteristic of UC. The Campsiandra laurifolia, known as acapurana, was described as possessing antioxi...
INTRODUCCIÓN: La colitis eosinofílica y la colitis de la enfermedad inflamatoria intestinal, son dos entidades que pueden compartir similares características clínicas, endoscópicas y terapéuticas pero diferentes criterios diagnósticos. OBJETIVOS: Describir el caso clínico de un niño preescolar c...
Colitis,
Enfermedades Inflamatorias del Intestino,
Eosinófilos,
Diarrea/diagnóstico,
Enterocolitis,
Hipersensibilidad a los Alimentos,
Hospitalización,
Uso Excesivo de Medicamentos Recetados,
Diarrea Infantil,
Dolor Abdominal,
Pediatría,
Enfermedades Gastrointestinales,
Eosinofilia,
Colon,
Colitis Ulcerosa,
Sistema Nervioso Entérico
García-Duperly, Rafael;
López-Panqueva, Rocío del Pilar;
Londoño-Schimmer, Eduardo Emilio;
Rey-Rubiano, Margarita;
Padrón-Mercado, Jorge;
Medellín-Abueta, Anwar;
Mejía-Arango, Marcela;
Aguirre-Matallana, Diego Andrés;
Ortiz-Pereira, Mónica Juliana;
Páez-Cancelado, Cristian Camilo;
Park Noh, Jong Hyuk;
Vallejo-Madroñero, Roberto Javier;
Gómez-Aldana, Andrés José;
Mendoza de Molano, Belén.
Abstract Introduction: Inflammatory bowel disease (IBD) is an immune-mediated disease whose incidence in Latin America has increased in recent years. Aim: To analyze the demographic and clinical characteristics of patients with IBD treated in a university hospital and present the epidemiological data c...
